Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism

YY Li, KY Yu, YJ Cui, ZJ Wang, HY Cai, JM Cao… - Neurobiology of …, 2023 - Elsevier
Dementia is the main clinical feature of Alzheimer's disease (AD). Orexin has recently been
linked to AD pathogenesis, and exogenous orexin-A (OXA) aggravates spatial memory …
被引用次数：5 相关文章

Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism.

YY Li, KY Yu, YJ Cui, ZJ Wang, HY Cai… - Neurobiology of …, 2023 - europepmc.org
Dementia is the main clinical feature of Alzheimer's disease (AD). Orexin has recently been
linked to AD pathogenesis, and exogenous orexin-A (OXA) aggravates spatial memory …

Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism

YY Li, KY Yu, YJ Cui, ZJ Wang, HY Cai… - Neurobiology of …, 2023 - pubmed.ncbi.nlm.nih.gov
Dementia is the main clinical feature of Alzheimer's disease (AD). Orexin has recently been
linked to AD pathogenesis, and exogenous orexin-A (OXA) aggravates spatial memory …

Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism.

YY Li, KY Yu, YJ Cui, ZJ Wang, HY Cai… - Neurobiology of …, 2023 - psycnet.apa.org
Dementia is the main clinical feature of Alzheimer's disease (AD). Orexin has recently been
linked to AD pathogenesis, and exogenous orexin-A (OXA) aggravates spatial memory …